Resmed Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€241.30
Target price
01.08.26
€262.86
Performance (%)
-13.59%
Price
30.12.25
€208.50
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.59%. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.530% | 0.530% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank Of Canada from $294.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat